Top

European Journal of Applied Physiology

Published in:

01-06-2020 | Diseases of the neuromuscular synapses and muscles | Invited Review

The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations

Authors: Allyson M. Schweitzer, Molly A. Gingrich, Thomas J. Hawke, Irena A. Rebalka

Published in: European Journal of Applied Physiology | Issue 6/2020

Abstract

Purpose

Statins are among the most widely prescribed medications worldwide. Considered the ‘gold-standard’ treatment for cardiovascular disease (CVD), statins inhibit HMG-CoA reductase to ultimately reduce serum LDL-cholesterol levels. Unfortunately, the main adverse event of statin use is the development of muscle-associated problems, referred to as SAMS (statin-associated muscle symptoms). While regular moderate physical activity also decreases CVD risk, there is apprehension that physical activity may induce and/or exacerbate SAMS. While much work has gone into identifying the epidemiology of SAMS, only recent research has focused on the extent to which these muscle symptoms are accompanied by functional declines. The purpose of this review is to provide an overview of possible mechanisms underlying SAMS and summarize current evidence regarding the relationship between statin treatment, physical activity, exercise capacity, and SAMS development.

Methods

PubMed and Google Scholar databases were used to search the most relevant and up-to-date peer-reviewed research on the topic.

Results

The mechanism(s) behind SAMS, including altered mitochondrial metabolism, reduced coenzyme Q10 levels, reduced vitamin D levels, impaired calcium homeostasis, elevated extracellular glutamate, and genetic polymorphisms, still lack consensus and remain up for debate. Our summation of the evidence leads us to suggest that the etiology of SAMS development is likely multifactorial. Our review also demonstrates that there is limited evidence for statins impairing exercise adaptations or reducing exercise capacity for the majority of the investigated populations.

Conclusion

The available evidence indicates that the benefits of engaging in physical activity while on statin medication largely outweigh the risks.

Agostini JV, Tinetti ME, Han L, McAvay G, Foody JAM, Concato J (2007) Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc 55:420–425. https://doi.org/10.1111/j.1532-5415.2007.01071.x CrossRefPubMed

Ahmed W, Khan N, Glueck CJ et al (2009) Low serum 25(OH) vitamin D levels (%3c 32ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 153:11–16. https://doi.org/10.1016/j.trsl.2008.11.002 CrossRefPubMed

Allard NAE, Schirris TJJ, Verheggen RJ et al (2018) Statins affect skeletal muscle performance: evidence for disturbances in energy metabolism. J Clin Endocrinol Metab 103:75–84. https://doi.org/10.1210/jc.2017-01561 CrossRefPubMed

American College of Sports Medicine Position Stand (1998) The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sport Exerc 30:975–991

Artinian NT, Fletcher GF, Mozaffarian D et al (2010) Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the american heart association. Circulation 122:406–441. https://doi.org/10.1161/CIR.0b013e3181e8edf1 CrossRefPubMedPubMedCentral

Baba TT, Nemoto TK, Miyazaki T, Oida S (2008) Simvastatin suppresses the differentiation of C2C12 myoblast cells via a Rac pathway. J Muscle Res Cell Motil 29:127–134. https://doi.org/10.1007/s10974-008-9146-9 CrossRefPubMed

Baar K, Wende AR, Jones TE (2002) Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB 16:1879–1886. https://doi.org/10.1096/fj.02-0367com CrossRef

Bahls M, GroB S, Ittermann T et al (2017) Statins are related to impaired exercise capacity in males but not females. PLoS ONE 12:1–14. https://doi.org/10.1371/journal.pone.0179534 CrossRef

Baptista LC, Veríssimo MT, Martins RA (2018) Statin combined with exercise training is more effective to improve functional status in dyslipidemic older adults. Scand J Med Sci Sport 28:2659–2667. https://doi.org/10.1111/sms.13284 CrossRef

Banach M, Serban C, Sahebkar A, Ursoniu S, Rysz J, Muntner P, Toth PP, Jones SR, Rizzo M, Glasser SP, Lip GY (2015) Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized control trials. Mayo Clin Proc 90:24–34. https://doi.org/10.1016/j.mayocp.2014.08.021 CrossRefPubMed

Benjamin EJ, Muntner P, Alonso A et al (2019) Heart disease and stroke statistics 2019 at a glance, stroke and other cardiovascular diseases. American Heart Association. https://healthmetrics.heart.org/wp-content/uploads/2019/02/at-a-glance-heart-disease-and-stroke-statistics. Accessed 10 Nov 2019

Berchtold MW, Brinkmeier H, Müntener M (2000) Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev 80:1215–1265. https://doi.org/10.1152/physrev.2000.80.3.1215 CrossRefPubMed

Bergstrom J, Furst P, Noree LO, Vinnars E (1974) Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol 36:693–697. https://doi.org/10.1152/jappl.1974.36.6.693 CrossRefPubMed

Berthold HK, Naini A, Di Mauro S et al (2006) Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomized control trial. Drug Saf 29:703–712. https://doi.org/10.2165/00002018-200629080-00007 CrossRefPubMed

Bogsrud MP, Langslet G, Ose L et al (2013) No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy. Scand Cardiovasc 47:80–87. https://doi.org/10.3109/14017431.2012.756119 CrossRef

Bookstaver DA, Burkhalter NA, Hatzigeorgiou C (2012) Effect of coenzyme Q10 supplementation on statin-induced myalgias. Am J Cardiol 110:526–529. https://doi.org/10.1016/j.amcard.2012.04.026 CrossRefPubMed

Bouitbir J, Gerda MS, Panajatovic MV, Singh F, Krähenbül S (2019) Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacol Res 154:104201CrossRef

Bouitbir J, Singh F, Charles AL et al (2016) Statins trigger mitochondrial reactive oxygen species-induced apoptosis in glycolytic skeletal muscle. Antioxidants Redox Signal 24:84–98. https://doi.org/10.1089/ars.2014.6190 CrossRef

Branch C (1998) Oxygen radicals and signaling Toren Finkel. Curr Opin Cell Biol 10:248–253. https://doi.org/10.1016/S0955-0674(98)80147-6 CrossRef

Brand MD (2010) The sites and topology of mitochondrial superoxide production. Exp Gerontol 45:466–472. https://doi.org/10.1016/j.exger.2010.01.003 CrossRefPubMedPubMedCentral

Broniarek I, Jarmuszkiewicz W (2018) Atorvastatin affects negatively respiratory function of isolated endothelial mitochondria. Arch Biochem Biophys 637:64–72CrossRef

Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B (2005) Mild to moderate muscular symptoms with high-dosage statin therapy in hyerplipidemic patients—the PRIMO study. Cardiovasc Drugs Ther 19:403–414. https://doi.org/10.1007/s10557-005-5686-z CrossRefPubMed

Brunham LR, Lansberg PJ, Zhang L et al (2012) Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin. Pharmacogenomics J 12:233–237. https://doi.org/10.1038/tpj.2010.92 CrossRefPubMed

Busanello ENB, Figueira TR, Marques AC, Navarro CDC, Oliveira HCF, Vercesi AE (2018) Facilitation of Ca2+-induced opening of the mitochondrial permeability transition pore either by nicotinamide nucleotide transhydrogenase deficiency or statins treatment. Cell Biol Int 42:742–746. https://doi.org/10.1002/cbin.10949 CrossRefPubMed

Busanello ENB, Marques AC, Lander N et al (2017) Pravastatin chronic treatment sensitizes hypercholesterolemic mice muscle to mitochondrial permeability transition: protection by creatine or coenzyme Q 10. Front Pharmacol 8:1–11CrossRef

Cairns BE, Hu JW, Arendt-Nielsen L, Sessle BJ, Svensson P (2001) Sex-related differences in human pain and rat afferent discharge evoked by injection of glutamate into the masseter musclce. J Neurophysiol 86:782–791. https://doi.org/10.1152/jn.2001.86.2.782 CrossRefPubMed

Cairns BE, Svensson P, Wang K et al (2003) Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol 90:2098–2105. https://doi.org/10.1152/jn.00353.2003 CrossRefPubMed

Camerino GM, Musumeci O, Conte E et al (2017) Risk of myopathy in patients in therapy with statins: identification of biological markers in a pilot study. Front Pharmacol. https://doi.org/10.3389/fphar.2017.00500 CrossRefPubMedPubMedCentral

Canadian Society for Exercise Physiology (2017) Physical activity training for health. www.csep.ca/guidelines. Accessed 10 Oct 2019

Cao P, Hanai J, Tanksale P, Imamura S, Sukhatme VP, Lecker SH (2009) Statin-induced muscle damage and atrogin-1 induction is the result of geranylgeranylation defect. FASEB J

Carr DF, Francis B, Jorgensen AL et al (2019) Genomewide association study of statin-induced myopathy in patients recruited using the UK clinical practice research datalink. Clin Pharmacol Ther 106:1353–1361. https://doi.org/10.1002/cpt.1557 CrossRefPubMedPubMedCentral

Caruso TJ, Fuzaylov G (2013) Severe vitamin D deficiency—rickets. N Engl J Med 369:494–495. https://doi.org/10.1056/NEJMicm1205540 CrossRef

Cohen JD, Brinton EA, Ito MK, Jacobson TA (2012) Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol 6:208–215. https://doi.org/10.1016/j.jacl.2012.03.003 CrossRefPubMed

Colivicchi F, Bassi A, Santini M, Caltagirone C (2007) Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke 38:2652–2657. https://doi.org/10.1161/STROKEAHA.107.487017 CrossRefPubMed

Dale KM, White CM, Henyan NN, Kluger J, Coleman CI (2007) Impact of statin dosing intensity on transaminase and creatine kinase. Am J Med 120:706–712. https://doi.org/10.1016/j.amjmed.2006.07.033 CrossRefPubMed

Davies KJA, Quintanilha AT, Brooks GA, Packer L (1982) Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 107:1198–1205. https://doi.org/10.1016/S0006-291X(82)80124-1 CrossRefPubMed

Davidson MH, Clark JA, Glass LM, Kanumalla A (2006) Statin safety: an appraisal from the adverse event reporting system. Am J Cardiol 97(S32):S43

DeGorter MK, Tirona RG, Schwarz UI et al (2013) Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care. Circ Cardiovasc Genet 6:400–408CrossRef

Deplanque D, Masse I, Libersa C, Leys D, Bordet R (2012) Previous leisure-time physical activity dose dependently decreases ischemic stroke severity. Stroke Res Treat. https://doi.org/10.1155/2012/614925 CrossRefPubMed

Dohlmann TL, Morville T, Kuhlman AB et al (2019) Statin treatment decreases mitochondrial respiration but muscle coenzyme Q10 levels are unaltered: the LIFESTAT study. J Clin Endocrinol Metab 104:2501–2508. https://doi.org/10.1210/jc.2018-01185 CrossRefPubMed

Donnelly LA, Doney ASF, Tavendale R et al (2011) Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a Go-DARTS study. Clin Pharmacol Ther 89:210–216. https://doi.org/10.1038/clpt.2010.255 CrossRefPubMed

Downs JR, Clearfield M, Weis S et al (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. J Am Med Assoc 279:1615–1622. https://doi.org/10.1001/jama.279.20.1615 CrossRef

du Souich P, Roederer G, Dufour R (2017) Myotoxicity of statins: mechanism of action. Pharmacol Ther 175:1–16CrossRef

Dykens JA, Will Y (2008) Drug-induced mitochondrial dysfunction. Wiley, HobokenCrossRef

Ebashi S, Endo M (1968) Calcium and muscle contraction. Prog Biophys Mol Biol. https://doi.org/10.1016/0079-6107(68)90023-0 CrossRefPubMed

Eisen A, Lev E, Iakobishvilli Z et al (2014) Low vitamin D levels and muscle-related adverse effects in statin users. Isr Med Assoc J 16:42–45PubMed

El-Salem K, Ababneh B, Rudnicki S et al (2011) Prevalence and risk factors of muscle complications secondary to statins. Muscle Nerve 44:877–881. https://doi.org/10.1002/mus.22205 CrossRefPubMed

Essen-Gustavsson B, Blomstrand E (2002) Effect of exercise on concentrations of free amino acid pools of type I and type II fibres in human muscle with reduced glycogen stores. Acta Physiol Scand 174:275–281. https://doi.org/10.1046/j.1365-201x.2002.00942.x CrossRefPubMed

Fernandez G, Spatz ES, Jablecki C, Phillips PS (2011) Statin myopathy: a common dilemma not reflected in clinical trials. Cleve Clin J Med 78:393–403. https://doi.org/10.3949/ccjm.78a.10073 CrossRefPubMed

Finegold JA, Manisty CH, Goldacre B, Barron AJ, Francis DP (2014) What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. Eur J Prev Cardiol 21:464–474. https://doi.org/10.1177/2047487314525531 CrossRefPubMed

Fagard RH (2006) Exercise is good for your blood pressure: effects of endurance training and resistance training. Clin Exp Pharmacol Physiol 33:854–856. https://doi.org/10.1111/j.1440-1681.2006.04453.x CrossRef

Fulcher J, O’Connell R, Voysey M et al (2018) Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet 385:1397–1405. https://doi.org/10.1016/S0140-6736(14)61368-4 CrossRef

Ganga HV, Slim HB, Thompson PD (2014) A systematic review of statin-induced muscle problems in clinical trials. Am Heart J 168:6–15. https://doi.org/10.1016/j.ahj.2014.03.019 CrossRefPubMed

Gerdle B, Ernberg M, Mannerkorpi K et al (2016) Increased interstitial concentrations of glutamate and pyruvate in vastus lateralis of women with fibromyalgia syndrome are normalized after an exercise intervention—a case-control study. PLoS ONE 11:1–24. https://doi.org/10.1371/journal.pone.0162010 CrossRef

Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE (2013) The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev 34:33–83. https://doi.org/10.1210/er.2012-1012 CrossRefPubMed

Glerup H, Mikkelsen K, Poulsen L et al (2000) Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419–424. https://doi.org/10.1007/s002230010085 CrossRefPubMed

Gluba-Brzozka A, Franczyk B, Toth PP, Rysz J, Banach M (2016) Molecular mechanisms or statin intolerance. Arch Med Sci 12:645CrossRef

Glueck CJ, Abuchaibe C, Wang P (2011a) Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle. Med Hypotheses 77:658–661. https://doi.org/10.1016/j.mehy.2011.07.007 CrossRefPubMed

Glueck CJ, Budhani SB, Masineni SS et al (2011b) Vitamin D deficiency, myositis-myalgia and reversible statin intolerance. Curr Med Res Opin 27:1683–1690. https://doi.org/10.1185/03007995.2011.598144 CrossRefPubMed

Golomb BA (2005) Implications of statin adverse effects in the elderly. Expert Opin Drug Saf 4:389–397. https://doi.org/10.1517/14740338.4.3.389 CrossRefPubMed

Gollnick PD, Körge P, Karpakka J, Saltin B (1991) Elongation of skeletal muscle relaxation during exercise is linked to reduced calcium uptake by the sarcoplasmic reticulum in man. Acta Physiol Scand 142(1):135–136CrossRef

Graham TE, Sgro V, Friars D, Gibala MJ (2000) Glutamate ingestion: the plasma and muscle free amino acid pools of resting humans. Am J Physiol Endocrinol Metab 278:83–89. https://doi.org/10.1152/ajpendo.2000.278.1.e83 CrossRef

Gu Q, Paulose-Ram R, Burt VL, Kit BK (2014) Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003–2012. NCHS Data Brief 177:1–8

Gupta A, Thompson D, Whitehouse A et al (2017) Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension. Lancet 389:2473–2481. https://doi.org/10.1016/S0140-6736(17)31075-9 CrossRefPubMed

Hamanaka RB, Chandel NS (2010) Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci 35:505–513. https://doi.org/10.1016/j.tibs.2010.04.002 CrossRefPubMedPubMedCentral

Hawke TJ, Garry DJ (2001) Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91:534–551. https://doi.org/10.1152/jappl.2001.91.2.534 CrossRefPubMed

Heesch KC, van Uffelen JGZ, van Gellecum YR, Brown WJ et al (2012) Dose-response relationships between physical activity, walking and health-related quality of life in mid-age and older women. J Epidemiol Community Health 66:670–677. https://doi.org/10.1136/jech-2011-200850 CrossRefPubMed

Henderson RM, Lovato L, Miller ME et al (2016) Effect of statin use on mobility disability and its prevention in at-risk older adults: the LIFE study. J Gerontol Ser A Biol Sci Med Sci 71:1519–1524. https://doi.org/10.1093/Gerona/glw057 CrossRef

Hennessy DA, Tanuseputro P, Tuna M et al (2016) Population health impact of statin treatment in Canada. Heal Rep 27:20–28

Herghelegiu AM, Prada GI, Nacu RM, Kozma A, Alexa ID (2018) Statins use and risk of sarcopenia in community dwelling older adults. Farmacia 66:702–707. https://doi.org/10.31925/farmacia.2018.4.21 CrossRef

Hu Y, Mitchell KM, Albahadily FN, Michaelis EK, Wilson GS (1994) Direct measurement of glutamate release in the brain using a dual enzyme-based electrochemical sensor. Brain Res 659:117–125. https://doi.org/10.1016/0006-8993(94)90870-2 CrossRefPubMed

Hubáček JA, Dlouhá D, Adámková V, Zlatohlavek L, Viklicky O, Hrubá P, Ceška R, Vrablik M (2015) SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population. Med Sci Monit Int Med J Exper Clin Res 21:1454

Hupin D, Roche F, Gremeaux V et al (2015) Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged ≥ 60 years: a systematic review and meta-analysis. Br J Sports Med 49:1262–1267. https://doi.org/10.1136/bjsports-2014-094306 CrossRefPubMed

Hurley BF, Hagberg J (1998) Optimizing health in older persons: aerobic or strength training? Exerc Sport Sci Rev 26:61–90CrossRef

Hurley BF, Roth SM (2000) Strength training in the elderly. Sport Med 30:249–268. https://doi.org/10.2165/00007256-200030040-00002 CrossRef

Istvan ES, Deisenhofer J (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292:1160–1164. https://doi.org/10.1126/science.1059344 CrossRefPubMed

James AM, Smith RAJ, Murphy MP (2004) Antioxidant and prooxidant properties of mitochondrial coenzyme Q10. Arch Biochem Biophys 423:47–56. https://doi.org/10.1016/j.abb.2003.12.025 CrossRefPubMed

Jurkat-Rott K, Lehmann-Horn F (2005) Muscle channelopathies and critical points in functional and genetic studies. J Clin Invest 115:2000–2009. https://doi.org/10.1172/JCl25525 CrossRefPubMedPubMedCentral

Kelly JP, Dunning A, Schulte PJ et al (2016) Statins and exercise training response in heart failure patients: insights from HF-ACTION. JACC Hear Fail 4:617–624. https://doi.org/10.1016/j.jchf.2016.05.006 CrossRef

Khayznikov M, Hemachrandra K, Pandit R, Kuman A, Wang P, Glueck CJ (2015) Statin intolerance because of myalgia, myositis, myopathy, or myonecrosis can in most cases be safely resolved by vitamin D supplementation. N Am J Med Sci 7:86–93. https://doi.org/10.4103/1947-2714.153919 CrossRefPubMedPubMedCentral

Kline ER, Bassit L, Hernandez-Santiago BJ et al (2009) Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction. Cardiovasc Toxicol 9:1–12CrossRef

König D, Deibert P, Winkler K, Berg A (2005) Association between LDL-cholesterol, statin therapy, physical activity and inflammatory markers in patients with stable coronary heart disease. Exerc Immunol Rev 11:97–107PubMed

Kraschnewski JL, Sciamanna CN, Poger JM et al (2016) Is strength training associated with mortality benefits? A 15 year cohort study of US older adults. Prev Med (Baltim) 87:121–127. https://doi.org/10.1016/j.ypmed.2016.02.038 CrossRef

Kubota Y, Evenson KR, Maclehose RF, Roetker NS, Joshu CE, Folsom AR (2017) Physical activity and lifetime risk of cardiovascular disease and cancer. Med Sci Sports Exerc 49:1599–1605. https://doi.org/10.1249/MSS.0000000000001274 CrossRefPubMedPubMedCentral

Kurnik D, Hochman I, Vesterman-Landes J et al (2012) Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins. Clin Endocrinol (Oxf) 77:36–41. https://doi.org/10.1111/j.1365-2265.2011.04321.x CrossRef

Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326:1423CrossRef

Lefferts WK, Deblois JP, Receno CN et al (2018) Effects of acute aerobic exercise on arterial stiffness and cerebrovascular pulsatility in adults with and without hypertension. J Hypertens 36:1743–1752. https://doi.org/10.1097/HJH.0000000000001752 CrossRefPubMed

Lee DSH, Markwardt S, Goeres L et al (2014) Statins and physical activity in older men: the osteoporotic fractures in men study. JAMA Intern Med 174:1263–1270. https://doi.org/10.1001/jamainternmed.2014.2266 CrossRefPubMedPubMedCentral

Loenneke JP, Loprinzi PD (2018) Statin use may reduce lower extremity peak force via reduced engagement in muscle-strengthening activities. Clin Physiol Funct Imaging 38:151–154. https://doi.org/10.1111/cpf.12375 CrossRefPubMed

Lynch T, Price A (2007) The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician 76:391–396PubMed

MacLennan DH, Brandl CJ, Korczak B, Green NM (1985) Amino-acid sequence of Ca2++Mg2+-dependent ATPase from rabbit skeletal muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence. Nature 317:831. https://doi.org/10.1038/317831d0 CrossRef

Majerczak J, Karasinski I, Zoladz AA (2008) Training induced decrease in oxygen cost of cycling is accompanied by down regulation of SERCA expression in vastus lateralis muscle. Acta Physiol Polonica 59:589

Mallinson JE, Marimuthu K, Murton A et al (2015) Statin myalgia is not associated with reduced muscle strength, mass or protein turnover in older male volunteers, but is allied with a slowing of time to peak power output, insulin resistance and differential muscle mRNA expression. J Physiol 593:1239–1257. https://doi.org/10.1113/jphysiol.2014.285577 CrossRefPubMedPubMedCentral

Mancini GBJ, Baker S, Bergeron J et al (2011) Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian working group consensus conference. Can J Cardiol 27:635–662. https://doi.org/10.1016/j.cjca.2011.05.007 CrossRefPubMed

Mann S, Beedie C, Jimenez A (2014) Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med 44:211–221CrossRef

Matsubara T, Urata M, Nakajima T et al (2018) Geranylgeranyliol-induced myogenic differentiation of C2C12 cells. Vivo 32:1427–1432. https://doi.org/10.21873/invivo.11395 CrossRef

Marchi S, Patergnani S, Missiroli S et al (2018) Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death. Cell Calc 69:62–67. https://doi.org/10.1016/j.ceca.2017.05.003 CrossRef

Martini C, Trapani L, Narciso L, Marino M, Trentalance A, Pallottini V (2009) 3-hydroxy 3-methylglutaryl coenzyme A reductase increase is essential for rat muscle differentiation. J Cell Physiol 220:524–530. https://doi.org/10.1002/jcp.21810 CrossRefPubMed

Marcoff L, Thompson PD (2007) The role of coenzyme Q10 in statin-associated myopathy. A systematic review. J Am Coll Cardiol 49(2231):2237. https://doi.org/10.1016/j.jacc.2007.02.049 CrossRef

Marot A, Morelle J, Chouinard VA, Jadoul M, Lambert M, Demoulin N (2000) Concomitant use of simvastatin and amiodarone resulting in severe rhabdomyolysis: a case report and review of the literature. Acta Clin Beig 66:134–136. https://doi.org/10.2143/ACB.66.2.20625533 CrossRef

Matuszek MA, Grant R (2018) Statins do not impair whole-body fat oxidation during moderate-intensity exercise in dyslipidemic adults. Exerc Med 2:12. https://doi.org/10.26644/em.2018.012 CrossRef

Mavros Y, Gates N, Wilson GC et al (2017) Mediation of cognitive function improvements by strength gains after resistance training in older adults with mild cognitive impairment: outcomes of the study of mental and resistance training. J Am Geriatr Soc 65:550–559. https://doi.org/10.1111/jgs.14542 CrossRefPubMed

McGinnis B, Olson KL, Magid D et al (2007) Factors related to adherence to statin therapy. Ann Pharmacother 41:1805–1811. https://doi.org/10.1345/aph.1K209 CrossRefPubMed

McMurray JJV, Dunselman P, Wedel H et al (2010) Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol 56:1196–1204CrossRef

McPhee JS, French DP, Jackson D, Nazroo J, Pendleton N, Degens H (2016) Physical activity in older age: perspectives for healthy ageing and frailty. Biogerontology 17:567–580. https://doi.org/10.1007/s10522-016-9641-0 CrossRefPubMedPubMedCentral

Meyer du Schwabediseen HE, Albers M, Baumeister SE et al (2015) Function-impairing polymorphisms of the hepatic uptake transporter SLCO1B1 modify the therapeutic efficacy of statins in a population-based cohort. Pharmacogenet Genomics 25:8–18. https://doi.org/10.1097/FPC.0000000000000098 CrossRef

Michalska-Kasiczak M, Sahebkar A, Mikhailidis DP et al (2015) Analysis of vitamin D levels in patients with and without statin-associated myalgia—a systematic review and meta-analysis of 7 studies with 2420 patients. Int J Cardiol 178:111–116. https://doi.org/10.1016/j.ijcard.2014.10.118 CrossRefPubMed

Mikami Y, Yamazawa T (2015) Chlorogenic acid, a polyphenol in coffee, protects neurons against glutamate neurotoxicity. Life Sci 139:69–74. https://doi.org/10.1016/j.lfs.2015.08.005 CrossRefPubMed

MoBhammer D, Schaeffeler E, Schwab M, Mörike K (2014) Mechanisms and assessment of statin-related muscular adverse effects. Br J Clin Pharmacol 78:454–466. https://doi.org/10.1111/bcp.12360 CrossRef

Molina-sotomayor E, Arreguín-moreno R, Rodríguez-rodríguez F (2018) Effects of exercise on the cognition of older women treated with lovastatin. Biomédica 38:496–506CrossRef

Morrison JT, Longnecker CT, Mittelsteadt A, Jiang Y, Debanne SM, McComsey GA (2016) Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy. HIV Clin Trials 17:140–146. https://doi.org/10.1080/15284336.2016.1184863 CrossRefPubMedPubMedCentral

Morville T, Dohlmann TL, Kuhlman AB et al (2019) Aerobic exercise performance and muscle strength in statin users—the LIFESTAT study. Med Sci Sports Exerc 51:1429–1437. https://doi.org/10.1249/MSS.0000000000001920 CrossRefPubMed

Myers J, McAuley P, Lavie CJ, Despres JP, Arena R, Kokkinos P (2015) Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status. Prog Cardiovasc Dis 57:306–314. https://doi.org/10.1016/j.pcad.2014.09.011 CrossRefPubMed

Newsholme P, Procopio J, Ramos Lima MM, Pithon-Curi TC, Curi R (2003) Glutamine and glutamate—their central role in cell metabolism and function. Cell Biochem Funct 21:1–9. https://doi.org/10.1002/cbf.1003 CrossRefPubMed

Nguyen KA, Li L, Lu D et al (2018) A comprehensive review and meta-analysis of risk factors for statin-induced myopathy. Eur J Clin Pharmacol 74:1099–1109. https://doi.org/10.1007/s00228-018-2482-9 CrossRefPubMed

Niemi M (2010) Transporter pharmacogenetics and statin toxicity. Clin Pharmacol Ther 87:130–133. https://doi.org/10.1038/clpt.2009.197 CrossRefPubMed

Niemi M, Schaeffeler E, Lang T et al (2004) High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics 14:429–440. https://doi.org/10.1097/01.fpc.0000114750.08559.32 CrossRefPubMed

Nunes-Silva A, Bernardes PTT, Rezende BM et al (2014) Treadmill exercise induces neutrophil recruitment into muscle tissue in a reactive oxygen species-dependent manner. An intravital microscopy study. PLoS ONE. https://doi.org/10.1371/journal/pone.0096464 CrossRefPubMedPubMedCentral

O’Donnell CJ, Elosua R (2008) Cardiovascular risk factors. Insights from Framingham heart study. Rev Esp Cardiol 61:299–310. https://doi.org/10.1157/13116658 CrossRefPubMed

Oja P, Kelly P, Pedisic Z et al (2017) Associations of specific types of sports and exercise with all-cause and cardiovascular-disease mortality: a cohort study of 80 306 British adults. Br J Sports Med 10:812–817. https://doi.org/10.1136/bjsports-2016-096822 CrossRef

Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4:552–565. https://doi.org/10.1038/nrm1150 CrossRefPubMed

Otrocka-Domagala I, Paździor-Czapula K (2018) Simvastatin impairs the inflammatory and repair phases of the postinjury skeletal muscle regeneration. Biomed Res Int. https://doi.org/10.1155/2018/7617312 CrossRefPubMedPubMedCentral

Ozdemir O, Boran M, Gokce V, Uzun Y (2000) A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy: a case report. Angiology 51:695PubMed

Paffenbarger RS, Blair SN, Lee IM (2001) A history of physical activity, cardiovascular health and longevity: the scientific contributions of Jeremy N Morris, DSc, DPH, FRCP. Int J Epidemiol 5:1184–1192. https://doi.org/10.1093/ije/30.5.1184 CrossRef

Panajatovic MV, Singh F, Roos NJ et al (2019) PGC-1a plays a pivotal role in simvastatin-induced exercise impairment in mice. Acta Physiol 2019:3. https://doi.org/10.1111/apha.13402 CrossRef

Panayiotou G, Paschalis V, Nikolaidis MG et al (2013) No effects of statins on muscle function and health-related parameters in the elderly: an exercise study. Scand J Med Sci Sport 23:556–567. https://doi.org/10.1111/j.1600-0838.2011.01437.x CrossRef

Panza GA, Taylor BA, Thompson PD et al (2016) The effects of atorvastatin on habitual physical activity among healthy adults. Med Sci Sport Exerc 48:1–6. https://doi.org/10.1249/MSS.0000000000000740 CrossRef

Parker BA, Augeri AL, Capizzi JA et al (2012) Effect of statins on creatine kinase levels before and after a marathon run. Am J Cardiol 109:282–287. https://doi.org/10.1016/j.amjcard.2011.08.045 CrossRefPubMed

Parker BA, Capizzi JA, Grimaldi AS et al (2013) Effects of statins on skeletal muscle function. Circulation 127:96–103. https://doi.org/10.1161/CIRCULATIONAHA.112.136101 CrossRefPubMed

Parker BA, Thompson PD (2012) Effects of statins on skeletal muscle: exercise, myopathy, and muscle outcomes. Exerc Sports Sci Rev 40(4):188

Pasternak RC, Smith SC, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C (2002) ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cariol 40:567–572. https://doi.org/10.1016/S0735-1097(02)02030-2 CrossRef

Patel H, Alkhawam H, Madanieh R, Shah N, Kosmas CE, Vittorio TJ (2017) Aerobic vs anaerobic exercise training effects on the cardiovascular system. World J Cardiol 9:134. https://doi.org/10.4330/wjc.v9.i2.134 CrossRefPubMedPubMedCentral

Pedersen TR, Kjekshus J, Berg K et al (2004) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study. Atheroscler Suppl 5:81–87. https://doi.org/10.1016/j.atherosclerosissup.2004.08.027 CrossRefPubMed

Pencina MJ, Navar-Boggan AM, D’Agostino RB et al (2014) Application of new cholesterol guidelines to a population-based sample. N Engl J Med 370:1422–1431. https://doi.org/10.1056/NEJMoa1315665 CrossRefPubMed

Pérez-Castrillón JL, Abad Manteca L, Vega G, Del Pino MJ, De Luis D, Duenas Laita A (2010) Vitamin D levels and lipid response to atorvastatin. Int J Endocrinol 2010:4–7. https://doi.org/10.1155/2010/320721 CrossRef

Phillips PS, Haas RH, Bannykh S et al (2002) Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med 137:581–585CrossRef

Pinky NF, Wilkie CM, Barnes JR, Parsons MP (2018) Region-and-activity-dependent regulation of extracellular glutamate. J Neurosci 38:5351–5366. https://doi.org/10.1523/JNEUROSCI.3212-17.2018 CrossRefPubMedPubMedCentral

Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R (2008) Calcium and apoptosis: ER—mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 27:6407–6418. https://doi.org/10.1038/onc.2008.308 CrossRefPubMedPubMedCentral

Pryor WA (1982) Free radical biology: xenobiotics, cancer and aging. Ann N Y Acad Sci 393:1–22. https://doi.org/10.1111/j.1749-6632.1982.tb31228.x CrossRefPubMed

Qu H, Meng YY, Chai H et al (2018) The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials. Eur J Med Res 23:57. https://doi.org/10.1186/s40001-018-0353-6 CrossRefPubMedPubMedCentral

Ramkumar S, Raghunath A, Raghunath S (2016) Statin therapy: review of safety and potential side effects. Acta Cardiol Sin 32:631–639. https://doi.org/10.6515/ACS20160611A CrossRefPubMedPubMedCentral

Rasheed K, Sethi P, Bixby E (2013) Severe vitamin D deficiency induced myopathy associated with rhabdomyolysis. N Am J Med Sci 5:334–336. https://doi.org/10.4103/1947-2714.112491 CrossRefPubMedPubMedCentral

Rebalka IA, Cao AW, May LL et al (2019) Statin administration activates system xC- in skeletal muscle: a potential mechanism explaining statin-induced muscle pain. Am J Physiol Cell Physiol 317:C894–C899. https://doi.org/10.1152/ajpcell.00308.2019 CrossRefPubMed

Rebalka IA, Cao AW, Raleigh MJ et al (2017) Statin therapy negatively impacts skeletal muscle regeneration and cutaneous wound repair in type 1 diabetic mice. Front Physiol 8:1–9. https://doi.org/10.3389/fphys.2017.01088 CrossRef

Rengo JL, Callahan DM, Savage PD, Ades PA, Toth MJ (2016) Skeletal muscle ultrastructure and function in statin-tolerant individuals. Muscle Nerve 53:242–251. https://doi.org/10.1002/mus.24722 CrossRefPubMed

Rhee SG, Bae YS, Lee SR, Kwon J (2000) Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000:1–7. https://doi.org/10.1126/stke.2000.53.pe1 CrossRef

Riphagen IJ, Van Der Veer E, Muskiet FAJ, Dejongste MJL (2012) Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D. Curr Med Res Opin 28:1247–1252. https://doi.org/10.1185/03007995.2012.702102 CrossRefPubMed

Romaine SPR, Bailey KM, Hall AS, Balmforth AJ (2010) The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy. Pharmacogenomics J 10:1–11. https://doi.org/10.1038/tpj.2009.54 CrossRefPubMed

Rosendal L, Larsson B, Kristiansen J et al (2004) Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain 112:324–334. https://doi.org/10.1016/j.pain.2004.09.017 CrossRefPubMed

Roth SM, Ferrell RF, Hurley BF (1999) Strength training for the prevention and treatment of sarcopenia. J Nutr Heal Aging 4:143–155

Rott D, Leibowitz D, Goldenberg I, Klempfner R (2016) Effect of coenzyme Q10 supplementation on statin-induced myalgias, a randomized double-blind, placebo-controlled study. J Prev Med Care 1:16–22. https://doi.org/10.14302/issn.2474-3585.jpmc-15-704 CrossRef

Rutten EPA, Engelen MPKJ, Schols AMWJ, Deutz NEP (2005) Skeletal muscle glutamate metabolism in health and disease: state of the art. Curr Opin Clin Nutr Metab Care 8:41–51. https://doi.org/10.1097/00075197-200501000-00007 CrossRefPubMed

Santos PCJL, Gagliardi ACM, Miname MH et al (2012) SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia. Eur J Clin Pharmacol 68:273–279. https://doi.org/10.1007/s00228-011-1125-1 CrossRefPubMed

Sarchielli P, di Filippo M, Nardi K, Calabresi P (2007) Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep 11:343–351. https://doi.org/10.1007/s11916-007-0216-2 CrossRefPubMed

Sathasivam S, Lecky B (2008) Statin induced myopathy. BMJ 337:1159–1162. https://doi.org/10.1136/bmj.a2286 CrossRef

Schachter M (2005) Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 19:117–125. https://doi.org/10.1111/j.1472-8206.2004.00299.x CrossRefPubMed

Schwellnus MP, Swanevelder S, Jordaan E, Derman W, Van Rensburg DCJ (2018) Underlying chronic disease, medication use, history of running injuries and being a more experienced runner are independent factors associated with exercise-associated muscle cramping: a cross-sectional study in 15778 distance runners. Clin J Sport Med 28:289–298. https://doi.org/10.1097/JSM.0000000000000456 CrossRefPubMed

Scott D, Blizzard L, Fell J, Jones G (2009) Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM 102:625–633. https://doi.org/10.1093/qjmed/hcp093 CrossRefPubMed

Semple SJ (2012) Statin therapy, myopathy and exercise – a case report. Lipids Health Dis 11:11–13. https://doi.org/10.1186/1476-511X-11-40 CrossRef

Sena LA, Chandel NS (2012) Physciological roles of mitochondrial reactive oxygen species. Mol Cell 48:158–167. https://doi.org/10.1016/j.molcel.2012.09.025 CrossRefPubMedPubMedCentral

Sharman JE, La Gerche A, Coombes JS (2015) Exercise and cardiovascular risk in patients with hypertension. Am J Hypertens 28:147–158. https://doi.org/10.1093/ajh/hpu191 CrossRefPubMed

St-Pierre J, Lin J, Krauss S et al (2003) Bioenergetic analysis of peroxisome proliferator-activated receptor y coactivators 1a and 1B (PGC-1a and PGC-1B) in muscle cells. J Biol Chem 278:26579–26603. https://doi.org/10.1074/jbc.M301850200 CrossRef

Svensson P, Wang K, Arendt-Nielsen L, Cairns BE, Sessle B (2005) Pain effects of glutamate injection into human jaw or neck muscles. J Orofac Pain 19:109–118PubMed

Taylor BA, Lorson L, White CM, Thompson PD (2015) A randomized control trial of coenzyme Q10 in patients with confirmed statin myopathy. Atherosclerosis 238:329–335. https://doi.org/10.1016/j.atherosclerosis.2014.12.016 CrossRefPubMed

Thompson PD, Buchner D, Piña IL et al (2003) Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the council on clinical cardiology (subcommittee on exercise, rehabilitation, and prevention) and the council on nutrition, physical. Circulation 107:3109–3116. https://doi.org/10.1161/01.CIR.0000075572.40158.77 CrossRefPubMed

Thompson PD, Panza G, Zaleski A, Taylor B (2016) Statin-associated side effects. J Am Coll Cardiol 67:2395–2410. https://doi.org/10.1016/j.jacc.2016.02.071 CrossRefPubMed

Thompson PD, Zmuda JM, Domalik LJ, Zimet RJ, Staggers J, Guyton JR (1997) Lovastatin increases exercise-induced skeletal muscle injury. Metabolism 46:1206–1210. https://doi.org/10.1016/S0026-0495(97)90218-3 CrossRefPubMed

Toussirot E, Michel F, Meneveau N (2015) Rhabdomyolysis occurring under statins after intense physical activity in a marathon runner. Case Rep Rheumatol 2015:1–2. https://doi.org/10.1155/2015/721078 CrossRef

Toyama K, Sugiyama S, Oka H et al (2017) A pilot study: the beneficial effects of combined statin-exercise therapy on cognitive function in patients with coronary artery disease and mild cognitive decline. Intern Med 56:641–649. https://doi.org/10.2169/internalmedicine.56.7703 CrossRefPubMedPubMedCentral

Trapani L, Segatto M, La Rosa P et al (2012) 3-hydroxy 3-methylglutaryl coenzyme a reductase inhibition impairs muscle regeneration. J Cell Biochem 113:2057–2063. https://doi.org/10.1002/jcb.24077 CrossRefPubMed

Ungard RG, Seidlitz EP, Singh G (2014) Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain. Pain 155:28–36. https://doi.org/10.1016/j.pain.2013.08.030 CrossRefPubMed

Urso ML, Clarkson PM, Hittle D, Hoffman EP, Thompson PD (2005) Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins. Arterioscler Thromb Vasc Biol 25:2560–2566. https://doi.org/10.1161/01.ATV.0000190608.28704.71 CrossRefPubMed

Vujic A, Lerchenmüller C, Wu T et al (2018) Exercise induces new cardiomyocyte generation in the adult mammalian heart. Nat Commun 9:1–9. https://doi.org/10.1038/s41467-018-04083-1 CrossRef

Wang Z, Schuetz EG, Xu Y, Thummel KE (2013) Interplay between vitamin D and the drug metabolizing enzyme CYP34A. J Steroid Biochem Mol Biol 136:54–58. https://doi.org/10.1016/j.jsbmb.2012.09.012 CrossRefPubMed

Warburton DER, Nicol CW, Bredin SSD (2006) Health benefits of physical activity: the evidence. CMAJ 174:801–809CrossRef

Ward NC, Watts GF, Eckel RH (2019) Statin toxicity: mechanistic insights and clinical implications. Circ Res 124:328–350. https://doi.org/10.1161/CIRCRESAHA.118.312782 CrossRefPubMed

Westcott WL (2012) Resistance training is medicine: effects of strength training on health. Curr Sports Med Rep 11:209–216. https://doi.org/10.1249/JSR.0b013e31825dabb8 CrossRefPubMed

Winett RA, Carpinelli RN (2001) Potential health-related benefits of resistance training. Prev Med (Baltim) 33:503–513. https://doi.org/10.1006/pmed.2001.0909 CrossRef

Wu J, Song Y, Chen J (2009) Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report. Eur J Clin Pharmacol 65:1169–1174. https://doi.org/10.1007/s00228-009-0723-07 CrossRefPubMed

Wu Z, Camargo CA Jr, Khaw KT et al (2018) Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: secondary analysis from the randomized, double-blind, placebo-controlled ViDA study. Atherosclerosis 273:59–66CrossRef

Yeter E, Keles T, Durmaz T, Bozkurt E (2007) Rhabdomyolysis due to the additive effect of statin therapy and hypothyroidism: a case report. J Med Case Rep 1:2–3. https://doi.org/10.1186/1752-1947-1-130 CrossRef

Young JM, Florkowski CM, Molyneux SL et al (2007) Effect of coenzyme Q10 supplementation on simvastatin-induced myalgia. Am J Cardiol 100:1400–1403. https://doi.org/10.1016/j.amcard.2007.06.030 CrossRefPubMed

Yusuf S, Bosch J, Dagenais G et al (2016) Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 374:2021–2031. https://doi.org/10.1056/NEJMoa1600176 CrossRefPubMed

Zanetti HR, Gonçlaves A, Paranhos Lopes LT et al (2019) Effects of exercise training and statin use in people living with HIV with dyslipidemia. Med Sci Sports Exerc. https://doi.org/10.1249/mss.000000000000212 CrossRefPubMed

Zhang H, Plutzky J, Turchin A (2013) Re: discontinuation of statins in routine care settings. Ann Intern Med 159:75–76. https://doi.org/10.7326/0003-4819-159-1-201307020-00022 CrossRefPubMed

Zhou Q, Liao JK (2010) Pleiotropic effects of statins – basic research and clinical perspectives. Circ J 74:818–826. https://doi.org/10.1253/circj.CJ-10-0110 CrossRefPubMedPubMedCentral

Zoladz JA, Koziel A, Woyda-Ploszczyca A, Celichowski J, Jarmuszkiewicz W (2016) Endurance training increases the efficiency of rat skeletal muscle mitochondria. Pflügers Archiv Eur J Physiol 468:1709–1724CrossRef

Title: The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations
Authors: Allyson M. Schweitzer
Molly A. Gingrich
Thomas J. Hawke
Irena A. Rebalka
Publication date: 01-06-2020
Publisher: Springer Berlin Heidelberg
Keywords: Diseases of the neuromuscular synapses and muscles
Myalgie
Statins
Myalgia
Myopathy
Published in: European Journal of Applied Physiology / Issue 6/2020
Print ISSN: 1439-6319
Electronic ISSN: 1439-6327
DOI: https://doi.org/10.1007/s00421-020-04360-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2020

Linearity and repeatability of postural responses in relation to peak force and impulse of manually delivered perturbations: a preliminary study

Dietary nitrate does not acutely enhance skeletal muscle blood flow and vasodilation in the lower limbs of older adults during single-limb exercise

Exercise type and fat mass loss regulate breast cancer-related sex hormones in obese and overweight postmenopausal women

On the climbing performance enhancing effects of New Zealand blackcurrant extract

Effects of dual-task demands on the complexity and task performance of submaximal isometric handgrip force control

Corticospinal excitability is altered similarly following concentric and eccentric maximal contractions